Multiple Myeloma (MM) is a hematologic malignancy characterized by the accumulation of clonal plasma cells (PCs) within the bone marrow (BM), typically producing a monoclonal immunoglobulin (M-protein), readily detectable in blood and/or urine samples. This evidence concerns the gene MYOM2 and Miyoshi myopathy.